EDGAR Filing Documents for 0001193805-20-000200

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0001193805-20-000200

Filing Date

2020-02-13

Accepted

2020-02-13 12:47:06

Documents

Group Members

DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT IV, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq	Description	Document	Type	Size
1		e619371_sc13ga-orchard.htm	SC 13G/A	176459
	Complete submission text file	0001193805-20-000200.txt		178115

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017

Business Address

Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU

Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700

Orchard Therapeutics plc (Subject) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-90710 | Film No.: 20608515
SIC: 2836 Biological Products, (No Diagnostic Substances)